Biotech companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 20 biotech companies in the United States ranked by short interest, at 19.2%, ahead of Twist Bioscience (14.4%) and Kodiak Sciences (12.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Scholar Rock Holding19.2%
Median
9.77%
Combined market value
$742.5B
Countries
1

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Biotech companies in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%$5.9B$48.00 6.48% up 14% up United States
2Twist BioscienceTWST · Health Care14.4%$7.9B$116.35 3.88% up 340% up United States
3Kodiak SciencesKOD · Health Care12.4%$6.4B$97.81 1.04% up 396% up United States
4Halozyme TherapeuticsHALO · Health Care12.0%$10.9B$95.80 0.18% down 37% up United States
5ImmunityBioIBRX · Health Care11.9%$7.1B$6.70 7.03% up 193% up United States
6RepligenRGEN · Health Care11.0%$11B$172.67 6.47% up 5% up United States
7ExelixisEXEL · Health Care10.5%$16.7B$68.29 0.31% down 63% up United States
8CG OncologyCGON · Health Care10.3%$7.1B$80.00 1.34% up 85% up United States
9Krystal BiotechKRYS · Health Care10.3%$9.3B$315.34 5.62% up 46% up United States
10Kymera TherapeuticsKYMR · Health Care9.84%$10.3B$121.13 0.32% down 87% up United States
11VaxcytePCVX · Health Care9.70%$9.3B$58.52 1.48% down 22% up United States
12ImmunovantIMVT · Health Care8.96%$6.9B$33.17 0.12% down 43% up United States
13ModernaMRNA · Health Care8.20%$79.6B$196.79 4.84% down 755% up United States
14Adaptive BiotechnologiesADPT · Health Care7.09%$4.6B$28.46 0.11% down 88% up United States
15Revolution MedicinesRVMD · Health Care6.05%$34.6B$159.82 1.76% down 131% up United States
16Neurocrine BiosciencesNBIX · Health Care5.83%$16.5B$162.86 1.84% down 20% up United States
17Bio-TechneTECH · Health Care4.90%$11.4B$72.75 0.17% up 26% up United States
18BiogenBIIB · Health Care3.69%$37.2B$251.41 0.25% up 49% up United States
19AmgenAMGN · Health Care2.33%$240.1B$443.89 3.07% down 34% up United States
20Gilead SciencesGILD · Health Care1.72%$209.6B$168.98 0.75% down 33% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further.

Questions and answers

Which biotech companies in the United States rank first by short interest?

Scholar Rock Holding (19.2%), Twist Bioscience (14.4%) and Kodiak Sciences (12.4%) are the top three of the 20 biotech companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech companies in the United States are in this ranking?

20 are ranked by short interest.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by short interest have a combined market value of $742.5B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies in the United States by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.